A number of studies have indicated that there exist in blood, protein-like materials which are not readily precipitated by heat, by perchloric acid, by sulfosalicylic acid, or by high concentrations of trichloracetic acid. The concentration of such materials has been found to increase in the blood of patients afflicted with cancer as well as in patients with a number of other diseases.
In a program designed to elucidate the nature of this material and its possible significance in cancer, we have isolated the material from normal human plasma and have shown it to be a mixture of mucoproteins (1) . Improved methods for the determination of plasma mucoproteins have also been studied (1) . This paper is concerned with an investigation into the plasma mucoprotein level in two conditions in which the concentrations have been found to be increased over the normal levels.
EXPERIMENTAL
Most of the determinations were carried out using the determination of perchloric acid soluble, phosphotungstic acid-insoluble tyrosine 2 of plasma as previously described (1) . In certain experiments the carbohydrate content of this same fraction was determined in order to ascertain whether the carbohydrate-tyrosine ratio deviated significantly from normal in pathological sera.
Results on the determination of mucoproteintyrosine levels in the plasma of 337 normal individuals and 454 cancer patients are shown in Figure 1 . The normals were largely taken from negative premarital Wassermann sera. All of the cancer cases included in Figure 1 type or extent of the malignancy. The results shown in Figure 1 show that the normal plasma mucoprotein levels are in the range of 1 to 4 mg. of tyrosine content per 100 ml. plasma and averaging 2.7 + 0.05 mg.%o, whereas the serum from cancer patients ranges between 2 and 12 mg.%o averaging 6.1 + 0.13 mg.%o. There is considerable overlapping between the high normals and the low cancers, but the maximum frequencies are distinctly different in the two groups. These results are in general accord with the work of previous investigators using polarographic determination of sulfosalicylic acid filtrates of denatured serum as well as with studies on the "index of polypeptidemia" (2 to 10). Figure 2 shows the plasma mucoprotein level as a function of time in three pneumonia patients admitted to the hospital. It is seen that these patients had very high plasma mucoprotein levels initially when the body temperatures were at a maximum. These high levels fell to normal levels and paralleled the temperature and the recovery of the patient.
The observation that patients suffering from pyogenic infections have increased amounts of "protein split products" in the serum is in accord with the results of other investigators listed above. Crossley and his associates (11) indication as to the similarity of the material in normal plasma and from the patients with cancer or pneumonia is given in Table I which shows the tyrosine and carbohydrate content of the perchloric acid-soluble, phosphotungstic acid-insoluble material in plasma determined as previously described (1) . The results show that the carbohydrate/tyrosine ratios of the materials in plasma which are soluble in 0.6 M perchloric acid but are precipitated by phosphotungstic acid, are contant in spite of the quite marked deviations in absolute levels of tyrosine. Thus it may be concluded that the materials responsible for the increased mucoprotein levels in pneumonia and cancer (and presumably other conditions) are chemically similar to the mucoprotein that has been previously isolated from normal human plasma ( 1 ).
-
DISCUSSION
The data presented in this paper show that the plasma mucoproteins are increased over normal levels in a large percentage of patients with cancer. However, the increased levels are not constant or specific enough to be of great value as a diagnostic test for cancer. False positive tests are given in pneumonia and a number of other conditions. Likewise, false negative tests are given in many cancer patients, especially when the disease is not far advanced. However, levels of over 4 mg. of mucoprotein-tyrosine per 100 ml. of plasma are rarely found except under pathological conditions. A carefully controlled study of the possible use of the method for diagnosis of cancer of the upper gastrointestinal tract is currently in progress. The very fact that the plasma mucoproteins are elevated in diseases of such different etiology as cancer, pneumonia and myocardial infarctions (Simkin et al., 13) , suggests that some abnormality in protein metabolism may be common to all of these conditions. It will be of utmost importance to investigate the chemical composition and physicochemical properties of mucoprotein isolated from pathological plasma in order to determine whether they are similar to or different from those present in normal plasma. It will also be important to investigate the source of the plasma mucoproteins and to determine their physiological significance. 
